Refine search

Date
Tumour Site
Topics
Congress

605 results for ""

Unsustainable
Cancer Control Principles

Fair pricing in an unfair world — where is the value?

People think cancer care is unaffordable because of the high prices of cancer medicines. Some state that innovations in oncology mostly happen thanks to massive investments in the private sector.

By Dario Trapani
What do non-oncologists know about cancer care?

What do non-oncologists know about cancer care?

A survey reveals that physicians outside the field of oncology are insufficiently updated on the latest advances in cancer care, thus increasing the risk of providing misleading information and inadequate support to patients.

Optimising clinical trials for greater inclusiveness

Optimising clinical trials for greater inclusiveness

Oncologists are aiming to capitalise on lessons learned from the COVID-19 pandemic and design more inclusive clinical trials, optimise trial endpoints and make better use of real-world evidence.

Quality cancer care starts with training oncologists at the highest standards

Quality cancer care starts with training oncologists at the highest standards

Despite the encouraging findings of a new global survey demonstrating a high rate of uptake of the ESMO/ASCO Global Curriculum in Medical Oncology, resource limitations in lower-income regions as well as country-specific political circumstances may be hindering its implementation locally.

Bringing a child into a family’s battle with cancer

Bringing a child into a family’s battle with cancer

Available data now allows evidence-based treatment of cancer diagnosed during pregnancy and new therapies are improving many young patients’ survival prospects, but couples’ preferences and values must continue to guide medical teams even when hope is scarce

Andrew J.S. Furness

Biomarkers for immunotherapy: where are we?

The future is in the hands of tools built on combinations of biomarkers as no single biomarker is likely to reflect the complexity of the tumour microenvironment or account for tumour evolution

By Andrew J.S. Furness

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.